Rhumbline Advisers Enochian Biosciences Inc Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
A detailed history of Rhumbline Advisers transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Rhumbline Advisers holds 50,756 shares of ENOB stock, worth $233,477. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,756
Previous 45,197
12.3%
Holding current value
$233,477
Previous $207,000
12.56%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ENOB
# of Institutions
51Shares Held
14.7MCall Options Held
24KPut Options Held
19.1K-
Vanguard Group Inc Valley Forge, PA5.72MShares$26.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$16.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.57MShares$7.23 Million0.0% of portfolio
-
State Street Corp Boston, MA1.32MShares$6.09 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL595KShares$2.74 Million0.0% of portfolio
About Enochian Biosciences Inc
- Ticker ENOB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,950,000
- Market Cap $244M
- Description
- Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...